摘要
Dear Editor,The COVID-19 pandemic has driven great interest in the therapeutic potential of repurposed drugs with well-established benefits and safety profiles(toxicity,bioavailability,etc.),many of which act via signal transduction pathways.One category of such drugs is those that reduce acid production in gastroenterological contexts.
基金
This work was supported by TRR295,KF0339,and DFG PR1562/1-1
Portions of this work were also supported by the University of Virginia School of Data Science and by NSF CAREER award MCB-1350957.
